bpc-157 and thymosin beta 4 Alpha & Peptide Therapies | BPC 157,

Alternative routes like subcutaneous or oral administration have not been studied for joint health applications

He threw out options and steps forward IF I wanted to proceed but made it clear that it was my decision and didn't make me feel bad about saying no

Continuous, daily usage without breaks is generally not recommended due to the lack of extensive human data and potential risks 1 2

It showed promising fat loss results with minimal side effects

Both BPC-157 and TB-500 are research chemicals intended for laboratory and preclinical investigation only, and neither is approved by the FDA or any major regulatory agency